iifl-logo-icon 1

Advanced Enzyme Technologies Ltd Share Price

379.3
(1.84%)
Jul 22, 2024|03:32:55 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open372
  • Day's High382.7
  • 52 Wk High425.15
  • Prev. Close372.45
  • Day's Low366.1
  • 52 Wk Low291.1
  • Turnover (lac)539.89
  • P/E33.78
  • Face Value2
  • Book Value51.91
  • EPS11.02
  • Mkt. Cap (Cr.)4,241.49
  • Div. Yield1.37
No Records Found

Advanced Enzyme Technologies Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

372

Prev. Close

372.45

Turnover(Lac.)

539.89

Day's High

382.7

Day's Low

366.1

52 Week's High

425.15

52 Week's Low

291.1

Book Value

51.91

Face Value

2

Mkt Cap (₹ Cr.)

4,241.49

P/E

33.78

EPS

11.02

Divi. Yield

1.37

Advanced Enzyme Technologies Ltd Corporate Action

6 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

11 May 2024

12:00 AM

Dividend

Dividend Amount: 1.1

Record Date: 18 Jul, 2024

arrow

8 Jul 2023

12:00 AM

AGM

Announcement Date: 08 Jul, 2023

arrow

Advanced Enzyme Technologies Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Advanced Enzyme Technologies Ltd SHAREHOLDING SNAPSHOT

22 Jul, 2024|07:33 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 41.06%

Foreign: 41.06%

Indian: 1.95%

Non-Promoter- 20.11%

Institutions: 20.11%

Non-Institutions: 36.87%

Custodian: 0.00%

Share Price

Advanced Enzyme Technologies Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

22.37

22.37

22.36

22.35

Preference Capital

0

0

0

0

Reserves

558.11

502.97

457.99

413.1

Net Worth

580.48

525.34

480.35

435.45

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

272.79

283.47

247.35

yoy growth (%)

-3.76

14.6

Raw materials

-99.2

-96.3

-88.75

As % of sales

36.36

33.97

35.88

Employee costs

-39.31

-34.23

-32.6

-32.48

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

72.07

98.42

75.85

Depreciation

-9.56

-9

-8.81

-7.81

Tax paid

-17.56

-27.41

-17.89

Working capital

37.12

-10.33

26.58

-6.36

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

-3.76

14.6

Op profit growth

-27.86

31.19

EBIT growth

-26.75

28.03

Net profit growth

-23.23

22.52

61.47

3.81

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

623.87

540.64

529.38

501.84

443.99

Excise Duty

0

0

0

0

0

Net Sales

623.87

540.64

529.38

501.84

443.99

Other Operating Income

0

0

0

0

0

Other Income

36.66

25.46

6.42

8.85

5.64

Advanced Enzyme Technologies Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,568.65

123.313,76,323.69867.60.865,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,519.8

76.171,19,994.455310.662,259507.93

Cipla Ltd

CIPLA

1,485.5

32.291,19,928.541,038.40.573,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,144.45

33.511,15,173.541,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,636

25.851,10,759.071,034.80.65,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Advanced Enzyme Technologies Ltd

Management

Register Office

Registrar Office

Whole-time director

MUKUND MADHUSUDAN KABRA

Chairman (Non-Executive)

VASANT RATHI

Independent Director

Pramod Kasat

Company Sec. & Compli. Officer

Sanjay Basantani

Non-Exec & Non-Independent Dir

Rasika Rathi

Independent Director

Vindokumar Hiralal Jajoo

Non-Exec & Non-Independent Dir

Sunny Sharma

Independent Director

Rajshree Patel

Independent Director

NITIN JAGANNATH DESHMUKH

Independent Director

Vandana Tilak.

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Advanced Enzyme Technologies Limited (AETL) is largest Indian enzyme company that has transformed business globally in the manufacturing of enzymes by improving the fundamentals based on research and technology. The Company is engaged in the research and development, manufacturing and marketing of over 400 proprietary products developed from over 68 indigenous enzymes and probiotics. It has manufacturing facilities and research & development centers across India, Germany and the US. Advanced Enzyme Technologies Limited (AETL) was incorporated, as a Private Limited Company on March 15, 1989 under the provisions of the Companies Act, 1956 as Advanced Biochemicals Private Limited in Maharashtra. Pursuant to a Special Resolution passed by the Shareholders of the Company at the Extra-Ordinary General Meeting held on April 21, 1992, the Company was converted into a Public Limited Company and consequently, name of the Company got changed to Advanced Biochemicals Limited. A fresh Certificate of Incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra on May 28, 1992. Pursuant to a Special Resolution passed by the Shareholders of the Company at the Extra-Ordinary General Meeting held on August 8, 2005, name of the Company was further changed from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited. A fresh Certificate of Incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra, Mumbai on August 19,
Read More

Company FAQs

What is the Advanced Enzyme Technologies Ltd share price today?

Down Arrow

The Advanced Enzyme Technologies Ltd shares price on N/A is Rs.₹380 today.

What is the Market Cap of Advanced Enzyme Technologies Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Advanced Enzyme Technologies Ltd is ₹4249.31 Cr. as of 22 Jul ‘24

What is the PE and PB ratio of Advanced Enzyme Technologies Ltd?

Down Arrow

The PE and PB ratios of Advanced Enzyme Technologies Ltd is 33.78 and 7.17 as of 22 Jul ‘24

What is the 52 Week High and Low of Advanced Enzyme Technologies Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Advanced Enzyme Technologies Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Advanced Enzyme Technologies Ltd is ₹292 and ₹425.1 as of 22 Jul ‘24

What is the CAGR of Advanced Enzyme Technologies Ltd?

Down Arrow

Advanced Enzyme Technologies Ltd's CAGR for 5 Years at 18.44%, 3 Years at -2.97%, 1 Year at 24.02%, 6 Month at -2.72%, 3 Month at 1.96% and 1 Month at -1.76%.

What is the shareholding pattern of Advanced Enzyme Technologies Ltd?

Down Arrow

The shareholding pattern of Advanced Enzyme Technologies Ltd is as follows:
Promoters - 43.02 %
Institutions - 20.11 %
Public - 36.87 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.